ADMA Biologics financial statements

ADMA 바이오로직스NASDAQ:ADMA · Nasdaq · Healthcare · sector #16
$10.18+0.69%
2026-10-06 close · prelim

ADMA Biologics's published financial data is dated 2026-10-04. 2024 revenue was $426M. 2024 operating profit was $138M.

Reported results

ADMA Biologics notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q